Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Accumulated Expenses (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Accumulated Expenses for 6 consecutive years, with $5.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 1277.14% year-over-year to $5.8 million, compared with a TTM value of $5.8 million through Dec 2025, up 1277.14%, and an annual FY2025 reading of $5.8 million, up 1277.14% over the prior year.
  • Accumulated Expenses was $5.8 million for Q4 2025 at Treace Medical Concepts, down from $7.2 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $7.2 million in Q3 2025 and bottomed at $398000.0 in Q2 2023.
  • Average Accumulated Expenses over 5 years is $2.9 million, with a median of $1.6 million recorded in 2021.
  • The sharpest move saw Accumulated Expenses skyrocketed 1700.0% in 2021, then crashed 93.29% in 2023.
  • Year by year, Accumulated Expenses stood at $4.5 million in 2021, then soared by 37.58% to $6.2 million in 2022, then plummeted by 93.29% to $417000.0 in 2023, then rose by 0.72% to $420000.0 in 2024, then surged by 1277.14% to $5.8 million in 2025.
  • Business Quant data shows Accumulated Expenses for TMCI at $5.8 million in Q4 2025, $7.2 million in Q3 2025, and $427000.0 in Q1 2025.